133 related articles for article (PubMed ID: 18166271)
21. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.
Green MK; Barbieri EV; Brown BD; Chen KW; Devine DP
Neuropeptides; 2007 Dec; 41(6):399-410. PubMed ID: 17980908
[TBL] [Abstract][Full Text] [Related]
22. Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively.
Inoue M; Kawashima T; Allen RG; Ueda H
J Pharmacol Exp Ther; 2003 Jul; 306(1):141-6. PubMed ID: 12665541
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of the rhesus monkey nociceptin/orphanin FQ receptor.
Koga K; Ichikawa D; Nambu H; Azuma-Kanoh T; Sakai N; Takaki-Kawagoe H; Ozaki S; Ohta H
Genes Genet Syst; 2009 Oct; 84(5):319-25. PubMed ID: 20154418
[TBL] [Abstract][Full Text] [Related]
24. Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors.
Ciccocioppo R; de Guglielmo G; Hansson AC; Ubaldi M; Kallupi M; Cruz MT; Oleata CS; Heilig M; Roberto M
J Neurosci; 2014 Jan; 34(2):363-72. PubMed ID: 24403138
[TBL] [Abstract][Full Text] [Related]
25. Endogenous orphanin FQ/nociceptin is involved in the development of morphine tolerance.
Chung S; Pohl S; Zeng J; Civelli O; Reinscheid RK
J Pharmacol Exp Ther; 2006 Jul; 318(1):262-7. PubMed ID: 16595734
[TBL] [Abstract][Full Text] [Related]
26. Further evidence for an involvement of nociceptin/orphanin FQ in the pathophysiology of Parkinson's disease: a behavioral and neurochemical study in reserpinized mice.
Volta M; Mabrouk OS; Bido S; Marti M; Morari M
J Neurochem; 2010 Dec; 115(6):1543-55. PubMed ID: 20950413
[TBL] [Abstract][Full Text] [Related]
27. Tonic inhibition by orphanin FQ/nociceptin of noradrenaline neurotransmission in the amygdala.
Kawahara Y; Hesselink MB; van Scharrenburg G; Westerink BH
Eur J Pharmacol; 2004 Feb; 485(1-3):197-200. PubMed ID: 14757141
[TBL] [Abstract][Full Text] [Related]
28. Activation of 5-HT1A receptors in the rat basolateral amygdala induces both anxiolytic and antipanic-like effects.
Strauss CV; Vicente MA; Zangrossi H
Behav Brain Res; 2013 Jun; 246():103-10. PubMed ID: 23499701
[TBL] [Abstract][Full Text] [Related]
29. Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task.
Asth L; Correia N; Lobão-Soares B; De Lima TC; Guerrini R; Calo' G; Soares-Rachetti VP; Gavioli EC
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):33-41. PubMed ID: 25319847
[TBL] [Abstract][Full Text] [Related]
30. N-arachidonoyl-serotonin in the basolateral amygdala increases anxiolytic behavior in the elevated plus maze.
John CS; Currie PJ
Behav Brain Res; 2012 Aug; 233(2):382-8. PubMed ID: 22633963
[TBL] [Abstract][Full Text] [Related]
31. Microinjection of naltrexone into the central, but not the basolateral, amygdala blocks the anxiolytic effects of diazepam in the plus maze.
Burghardt PR; Wilson MA
Neuropsychopharmacology; 2006 Jun; 31(6):1227-40. PubMed ID: 16123750
[TBL] [Abstract][Full Text] [Related]
32. Administration of a delta opioid receptor agonist KNT-127 to the basolateral amygdala has robust anxiolytic-like effects in rats.
Sugiyama A; Yamada M; Saitoh A; Nagase H; Oka JI; Yamada M
Psychopharmacology (Berl); 2018 Oct; 235(10):2947-2955. PubMed ID: 30066134
[TBL] [Abstract][Full Text] [Related]
33. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.
Ciccocioppo R; Fedeli A; Economidou D; Policani F; Weiss F; Massi M
J Neurosci; 2003 Oct; 23(28):9445-51. PubMed ID: 14561874
[TBL] [Abstract][Full Text] [Related]
34. Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.
Gavioli EC; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb; 372(5):319-30. PubMed ID: 16491387
[TBL] [Abstract][Full Text] [Related]
35. The inactivation of the basolateral nucleus of the rat amygdala has an anxiolytic effect in the elevated T-maze and light/dark transition tests.
Bueno CH; Zangrossi H; Viana MB
Braz J Med Biol Res; 2005 Nov; 38(11):1697-701. PubMed ID: 16258641
[TBL] [Abstract][Full Text] [Related]
36. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety.
Pérez de la Mora M; Lara-García D; Jacobsen KX; Vázquez-García M; Crespo-Ramírez M; Flores-Gracia C; Escamilla-Marvan E; Fuxe K
Eur J Neurosci; 2006 May; 23(10):2749-59. PubMed ID: 16817878
[TBL] [Abstract][Full Text] [Related]
37. Anxiolytic-like effect of central administration of NOP receptor antagonist UFP-101 in rats submitted to the elevated T-maze.
Duzzioni M; Duarte FS; Leme LR; Gavioli EC; De Lima TC
Behav Brain Res; 2011 Sep; 222(1):206-11. PubMed ID: 21459118
[TBL] [Abstract][Full Text] [Related]
38. Antagonistic effects of CompB on orphanin FQ-induced colonic contractions in rats.
Tada H; Nakagawa K; Yamamura T; Takahashi T
Eur J Pharmacol; 2002 Nov; 454(1):53-8. PubMed ID: 12409005
[TBL] [Abstract][Full Text] [Related]
39. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines.
Pesold C; Treit D
Brain Res; 1995 Feb; 671(2):213-21. PubMed ID: 7743210
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological properties of nociceptin/orphanin FQ-induced stimulation and inhibition of cyclic AMP formation in distinct layers of rat olfactory bulb.
Olianas MC; Onali P
Br J Pharmacol; 2002 Jan; 135(1):233-8. PubMed ID: 11786499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
